ClearPoint Neuro (CLPT) EBIT Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.20% |
| Dec 31, 2025 | -25.48% |
| Sep 30, 2025 | -32.91% |
| Jun 30, 2025 | -30.95% |
| Mar 31, 2025 | -38.51% |
| Dec 31, 2024 | -31.78% |
| Sep 30, 2024 | -41.46% |
| Jun 30, 2024 | -29.58% |
| Mar 31, 2024 | -34.10% |
| Dec 31, 2023 | -36.89% |
| Sep 30, 2023 | -32.34% |
| Jun 30, 2023 | -34.24% |
| Mar 31, 2023 | -31.97% |
| Sep 30, 2021 | -17.35% |
| Jun 30, 2021 | -10.64% |
| Mar 31, 2021 | -2.43% |
| Sep 30, 2020 | 7.97% |
| Jun 30, 2020 | 11.27% |
| Mar 31, 2020 | 16.31% |
| Dec 31, 2019 | 11.94% |
| Sep 30, 2019 | 19.04% |
| Jun 30, 2019 | 10.21% |
| Mar 31, 2019 | -19.56% |
| Dec 31, 2018 | 13.89% |
| Sep 30, 2018 | 8.31% |
| Jun 30, 2018 | 5.57% |
| Mar 31, 2018 | -0.86% |
| Sep 30, 2016 | -3.63% |
| Jun 30, 2016 | -6.90% |
| Mar 31, 2016 | -2.52% |